Detalles de la búsqueda
1.
Carboplatin plus etoposide versus topotecan as second-line treatment for patients with sensitive relapsed small-cell lung cancer: an open-label, multicentre, randomised, phase 3 trial.
Lancet Oncol
; 21(9): 1224-1233, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32888454
2.
Safety and efficacy of second-line metronomic oral vinorelbine-atezolizumab combination in stage IV non-small-cell lung cancer: An open-label phase II trial (VinMetAtezo).
Lung Cancer
; 178: 191-197, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36868180
3.
Clinical Characteristics of Patients with Advanced ALK-Translocated Non-small Cell Lung Cancers and Long-Term Responses to Crizotinib (CRIZOLONG GFPC 05-19 Study).
Target Oncol
; 18(6): 905-914, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37966566
4.
Impact of KRAS G12C mutation in patients with advanced non-squamous non-small cell lung cancer treated with first-line pembrolizumab monotherapy.
Lung Cancer
; 174: 45-49, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36323057
5.
Multicenter phase II trial of nintedanib plus docetaxel in second-line treatment in advanced non-squamous non-small cell lung cancer patients refractory to first-line platin-based chemotherapy (REFRACT GFPC 02-15 study).
Lung Cancer
; 161: 122-127, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34583220
6.
Efficacy of Dabrafenib Plus Trametinib Combination in Patients with BRAF V600E-Mutant NSCLC in Real-World Setting: GFPC 01-2019.
Cancers (Basel)
; 12(12)2020 Dec 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33276639
7.
Management and outcomes of non-small cell lung cancer patients with rapid progression under second-or-more-line immune checkpoint inhibitors: ERORECI study (GFPC 2016-04).
Cancer Med
; 9(2): 432-439, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31747137
8.
Circulating free tumor-derived DNA to detect EGFR mutations in patients with advanced NSCLC: French subset analysis of the ASSESS study.
J Thorac Dis
; 11(4): 1370-1378, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-31179079
9.
Potential Antiangiogenic Treatment Eligibility of Patients with Squamous Non-Small-Cell Lung Cancer: EPISQUAMAB Study (GFPC 2015-01).
Cancer Manag Res
; 11: 10821-10826, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31920391
10.
Safety and Efficacy of Immune Checkpoint Inhibitors in Patients With Cancer and Preexisting Autoimmune Disease: A Nationwide, Multicenter Cohort Study.
Arthritis Rheumatol
; 71(12): 2100-2111, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31379105
11.
Transient HIV-specific T cells increase and inflammation in an HIV-infected patient treated with nivolumab.
AIDS
; 31(7): 1048-1051, 2017 Apr 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-28350581
Resultados
1 -
11
de 11
1
Próxima >
>>